Browse > Article
http://dx.doi.org/10.13045/jar.2020.00332

Single-dose and 4-week repeated dose Toxicity of Aconitum Sinomontanum Nakai Pharmacopuncture: An Experimental Study  

Woo, Sang Ha (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Lee, Jung Hee (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Lee, Cho-in (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Lee, Yun Kyu (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Lee, Hyun-Jong (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Kim, Jae Soo (Department of Acupuncture and Moxibustion medicine, College of Korean medicine, Daegu Hanni University)
Publication Information
Journal of Acupuncture Research / v.38, no.1, 2021 , pp. 47-59 More about this Journal
Abstract
Background: This study aimed to assess the toxicity of Aconitum sinomontanum Nakai (ASN) pharmacopuncture. Methods: To investigate the toxicity of ASN pharmacopuncture, single and 4-week repeated dose toxicity experiments were conducted on BALB/c mice. In the single-dose toxicity experiment, mice were assigned 1 of 4 groups (5 males, 5 females per group). Then, 31.25, 62.5, and 125 mg/kg of ASN pharmacopuncture were administered to the mice in the experimental groups at acupoint ST36, while 0.2 mL of normal saline was administered to the control group at ST36. After a 4-week repeated dose regimen, the mice were assigned into 4 groups (5 males, 5 females per group). Then, 15.625, 31.25, and 62.5 mg/kg of ASN pharmacopuncture at ST36 were administered to the mice in the experimental groups, while 0.2 mL of normal saline was administered to the control group at ST36. Mortality, morbidity, general body and organ weight changes (after 4 weeks repeated dose), serum hematological and biochemical values, and histopathological changes in the liver and kidney were observed. Results: In both single and 4-week repeated dose toxicity experiments, no deaths or symptoms occurred in any of the groups. There were no significant differences between groups in terms of body and organ weights, serum hematological and biochemical values, and specific organ histopathological changes. Conclusion: ASN pharmacopuncture injection did not demonstrate significant toxicity in BALB/c mice compared with the control group, with a no-observed-adverse-effect level for a single dose of >125 mg/kg, and for 4 weeks repeated dose it was more than 62.5 mg/kg/day.
Keywords
pharmacopuncture; toxicity; morbidity; body weight changes; hematologic test;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 National Institute of Food and Drug Safety Evaluation [Internet]. Guideline on Non-Clinical Documentation for Herbal Medicinal Product. [cited 2017 Oct 1]. Available from: https://www.nifds.go.kr/brd/m_15/list.do. [in Korean].
2 Ministry of Food & Drug Safety [Internet]. A Flow Chart on Toxicity Test of Medicine (2015). [cited 2015 Nov 11]. Available from: http://www.mfds.go.kr/index.do?mid=1013&seq=10128&cmd=v. [in Korean].
3 Park YC, Cho MH. A New Way in Deciding NOAEL Based on The Findings From GLP-Toxicity Test. Toxicol Res 2011;27:133-135.   DOI
4 Trevan JW. The Error of Determination of Toxicity. Proc R Soc Lond B Biol Sci 1927;101:483-514.   DOI
5 Choi SY. Toxicology. Ulsan (Korea); Ulsan University publishing department: 1987. p. 189-207, 298-299. [in Korean].
6 Kim SK, Kim KC, Lee BM. Mathematical and Statistical Characterization of LD (50) Estimation. Toxicol Res 2014;20:321-324.
7 Jung SY, kim GY, Kim BH, Jo YB. Toxicology. Seoul (Korea): Donghwa technology; 2000. p.15-21, 118-194. [in Korean].
8 Ko YS, Yun SH, Kim MK, Song YS, Shin BC. Literatural Study on Toxicity of Herbs used in . J Physiol Pathol Korean Med 2005;19:1120-1128. [in Korean].
9 Lee YJ, Hwang WD, Lee JW, Jeong HJ, Bae SH, Kim KG. The Study of Safety of Herbal Medicine Including Fuzi on High Range of LFT, RFT Patients. Herb Formula Sci 2011;19:179-189. [in Korean].   DOI
10 Park YC, Park HM, Lee SD. Inducible Mechanisms for Hepatotoxicity Caused by Traditional Korean Medicines in a View of Toxicology. J Korean Orient Med 2011;32:48-67. [in Korean].
11 Pessayre D, Larrey D, Biour M. Drug-induced liver injury. Oxford (UK): Oxford University Press; 1999. p. 1261-1315.
12 Jeongdam editorial department. Step to Internal Medicine part 5 Kidney (2018). Seoul (Korea): Jeongdam; 2016. 4 p. [in Korean].
13 Kim EJ, Kan DG, Lee AS, Choi DH, Cho KH, Kim SY et al. Study on Kidney Toxicity of BDR-29 for Treatment Vascular Diseases in Rat. Herb Formula Sci 2008;16:163-169. [in Korean].
14 Kim DW. The Change of Renal Function in Patients with Long Term Herb Medication by Frequently Prescribed Formular. J Physiol Pathol Korean Med 2004;18:1207-1212.
15 Deng X, Zheng LP, Mu ZQ, Lai R, Niu GP, Tu LP et al. The inhibitory effect of Aconiti Sinomontani Radix extracts on the proliferation and migration of human synovial fibroblast cell line SW982. J Ethnopharmacol 2018; 213:321-327.   DOI
16 Kim SY, Mun AR. Drug-Induced Nephrotoxicity and Its Biomarkers. Biomol Ther (Seoul) 2012;20:268-272.   DOI
17 Ren YS, Zhang P, Yan D, Wang JB, Du XX, Xiao XH. A Strategy for The Detention of Quality Fluctuation of A Chinese Herbal Injection Based on Chemical Fingerprinting Combined with Biological Fingerprinting. J Pharm Biomed Anal 2011;56:436-442.   DOI
18 Gao BZ. New Chinese Medicine Dictionary. middle Taibei (Taiwan); Xinwenli publishing company; 1982. 273 p. [in Chinese].
19 Hwa EU, Ryu SB, Yang JG, Yang HK, Yang CH, Ung SW et al. Junghwaboncho. Shanghai (China); Sanghai gichul publisher; 1999. p. 1746-1747. [in Chinese].
20 Lee JH[Dissertation]. The analgesic effect and safety of Aconitum sinomont anumNakaipharmacopuncture in Sprague-Dawley rats. Gyungsan (Korea): Daegu Haany University; 2019. p. 1-64. [in Korean].
21 Wang YZ, Xiao YQ, Zhang C, Sun XM. Study of analgesic and anti-inflammatory effects of lappaconitine gelata. J Tradit Chin Med 2009;29:141-145.   DOI
22 Sun ML, Ao JP, Wang YR, Huang Q, Li TF, Li XY et al. Lappaconitine, a C18-diterpenoid alkaloid, exhibits antihypersensitivity in chronic pain through stimulation of spinal dynorphin A expression. Psychopharmacology(Berl) 2018;235:2559-2571.   DOI
23 Korean Pharmacopuncture Institute. Pharmacopuncturology. Seoul (Korea); Elsevier Korea; 2008 p. 3-8. [in Korean].
24 Yang CL, Wei ZR, Zhang TH, Zeng XQ, Wu BH. Effects of lappaconitine on pain and inflammatory response of severely burned rats and the mechanism. Zhonghua Shao Shang Za Zhi 2017;33:374-380. [in Chinese].
25 Gong QA, Li M. Effect of Lappaconitine on Postoperative Pain and Serum Complement 3 and 4 Levels of Cancer Patients Undergoing Rectum Surgery. Zhongguo Zhong Xi Yi Jie He Za Zhi 2015;35:668-672. [in Chinese].